FRAIL-IMMUNE (GORTEC 2018-03) - Combination of Durvalumab With Carboplatin/Paclitaxel

Condition:   Squamous Cell Carcinoma of the Head and Neck
Intervention:   Drug: Durvalumab with Carboplatin/Paclitaxel
Sponsor:   Centre Leon Berard
Not yet recruiting

https://ift.tt/2Jrcltt